• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

PKCbeta1 Inhibitor – Pkcbeta 1

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759180

PKCbeta inhibitor 1(KUN79359) is a potent, selective and ATP-competitive inhibitor of PKCbeta isozymes(IC50s of 21 and 5nM for human PKCbeta1 and PKCbeta2, respectively). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
PKCbeta 1 (PKCbeta1 ), Inhibitor
Full Product Name
PKCbeta inhibitor 1
Product Gene Name
Product Synonym Names
PKCbeta inhibitor 1 ; KUN79359
Form/Format
Solid. Powder
Purity/Purification
100.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
411.5
Solubility
DMSO: 250mg/mL (607.59mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C24H21N5O2
SMILES
O=C(C(C1=CN(CCCN2C=CN=C2)C3=C1C=CC=C3)=C4NC5=CC=CC=C5)NC4=O
CAS Number
257879-35-9
Target & IC50
human PKCbeta1: ic50 21nM
human PKCbeta2: ic50 5nM
PKCalpha: ic50 331nM

Product Categories/Family for PKCbeta1 , inhibitor

Structure of PKCbeta1 , inhibitor

PKCbeta1 Inhibitor – Cat# MBS5759180

Product References and Citations for PKCbeta1 , inhibitor

1. Saba N S, Levy L S. Protein Kinase C-Beta Inhibition Induces Apoptosis and Inhibits Cell Cycle Progression in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin Lymphoma Cells[J]. Journal of Investigative Medicine, 2012, 60(1):29-.
Saba N S, Levy L S. Protein Kinase C-Beta Inhibition Induces Apoptosis and Inhibits Cell Cycle Progression in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin Lymphoma Cells[J]. Journal of Investigative Medicine, 2012, 60(1):29-.
2. Masahiro Tanaka, Shoichi Sagawa, Jun-ichi Hoshi,et al. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors[J]. Bioorganic & Medicinal Chemistry Letters, 2004, 14(20):5171-5174.
Masahiro Tanaka, Shoichi Sagawa, Jun-ichi Hoshi,et al. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors[J]. Bioorganic & Medicinal Chemistry Letters, 2004, 14(20):5171-5174.
3. Nikolai, Pakhomov, Ksenia,et al. Negative inotropic effects of diadenosine tetraphosphate are mediated by protein kinase C and phosphodiesterases stimulation in the rat heart[J]. European Journal of Pharmacology An International Journal, 2018.
Nikolai, Pakhomov, Ksenia,et al. Negative inotropic effects of diadenosine tetraphosphate are mediated by protein kinase C and phosphodiesterases stimulation in the rat heart[J]. European Journal of Pharmacology An International Journal, 2018.

Other Notes

Small volumes of PKCbeta1 , inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for PKCbeta1 purchase

MBS5759180 is an inhibitor targeting PKCbeta1 . Also known as PKCbeta inhibitor 1.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000